BioControl Medical Launches the INOVATE-HF IDE Study of Its CardioFit(R) System for Heart Failure

Published: Apr 26, 2011

YEHUD, Israel & NEW HOPE, Minn.--(BUSINESS WIRE)--BioControl Medical, a medical technology company that develops and markets advanced implantable devices for the treatment of autonomic disorders, has announced first patient enrollment in the INOVATE-HF (INcrease Of VAgal TonE in Heart Failure) clinical study at Northwest Texas Heart Hospital, Amarillo, Texas, by study investigator Suresh Neelagaru, M.D.

Back to news